Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF2R | P11717 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GJA1 | P17302 | 1/20 | 0.38 |
| ▸ | GJB2 | P29033 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17938837 | 0.89 | L3MBTL1 (0.46) | IGF2RL3MBTL1LGALS8GAATYR | |
| SCHEMBL27494277 | 0.86 | IGF2R (0.44) | IGF2RL3MBTL1LGALS8GAATYR | |
| SCHEMBL28635537 | 0.84 | LGALS8 (0.44) | IGF2RL3MBTL1LGALS8GAATYR | |
| SCHEMBL30705725 | 0.83 | KDM4E (0.44) | L3MBTL1LGALS8GAATYRMAPT | |
| SCHEMBL2786780 | 0.82 | SLC28A3 (0.45) | L3MBTL1LGALS8MAPTSLC28A3ALDH1A1 | |
| SCHEMBL17080327 | 0.80 | PYGB (0.51) | L3MBTL1LGALS8GAAMAPTSLC28A3 | |
| SCHEMBL8431126 | 0.80 | PYGB (0.51) | L3MBTL1LGALS8GAAMAPTSLC28A3 | |
| SCHEMBL17080326 | 0.80 | PYGB (0.51) | L3MBTL1LGALS8GAAMAPTSLC28A3 | |
| SCHEMBL546798 | 0.80 | PYGB (0.51) | L3MBTL1LGALS8GAAMAPTSLC28A3 | |
| SCHEMBL1098586 | 0.79 | LGALS8 (0.45) | L3MBTL1LGALS8GAATYRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273725-A1 | Novel compounds useful in therapeutic and cosmetic methods | PHOTODERMA SA (CH) | 2010-10-28 | — | — | US | disclosed |
| US-20100273725-A1 | Novel compounds useful in therapeutic and cosmetic methods | PHOTODERMA SA (CH) | 2010-10-28 | — | — | US | disclosed |
| WO-2009077960-A1 | NOVEL COMPOUNDS USEFUL IN THERAPEUTIC AND COSMETIC METHODS | PHOTODERMA SA (CH) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273725-A1 | Novel compounds useful in therapeutic and cosmetic methods | ALAD, CUTA, AADAT | IGF2R 2947/4885L3MBTL1 4255/4885LGALS8 814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.